...
机译:CD62P和凝血酶生成表达对利用中央静脉导管血液透析患者的影响
Department of NursingFederal University of the Valleys of Jequitinhonha and MucuriDiamantina Brazil;
Department of Clinical and Toxicological AnalysisFederal University of Minas GeraisBelo Horizonte;
Department of Clinical and Toxicological AnalysisFederal University of Minas GeraisBelo Horizonte;
Department of Mechanical EngineeringFederal University of Minas GeraisBelo Horizonte Brazil;
Department of NursingFederal University of the Valleys of Jequitinhonha and MucuriDiamantina Brazil;
Department of PharmacyFederal University of the Valleys of Jequitinhonha and MucuriDiamantina Brazil;
Department of Clinical and Toxicological AnalysisFederal University of Minas GeraisBelo Horizonte;
Department of PharmacyFederal University of the Valleys of Jequitinhonha and MucuriDiamantina Brazil;
Department of Mechanical EngineeringFederal University of Minas GeraisBelo Horizonte Brazil;
central venous catheters; hemodialysis; platelets; thrombin generation test;
机译:CD62P和凝血酶生成表达对利用中央静脉导管血液透析患者的影响
机译:血液透析患者中的中心静脉狭窄通常与先前的中心静脉导管无关。
机译:抗微生物锁定解决方案是否会降低血液透析患者的导管相关感染中央静脉导管? 贝叶斯网络元分析
机译:用于监测中央静脉导管中的生物层形成的阻碍方法,用于血液透析的血液透析
机译:利用基于团队的系统方法来减少透析患者的中心静脉导管率
机译:需要急性期肾衰竭的肾脏替代疗法的患者中使用非肝性中央静脉血液透析导管的肝素与柠檬酸作为导管锁定溶液的比较(VERROU-REA研究):一项随机对照试验的研究方案
机译:中心静脉导管血液透析患者血流感染发生率中心静脉导管血液透析患者血流感染发生率中心静脉导管血液透析患者血流感染发生率